Xanthomas Regression in an 8-Year-Old Boy Treated With Lomitapide
This case reports on an 8-year-old boy with homozygous familial hypercholesterolemia with large tuberous xanthomas over his hands, elbows, buttocks, knees, and feet. Lomitapide 40 mg daily (steadily increased) was added to his classical lipid-lowering therapy. A 50% reduction in the thickness, hardn...
Main Authors: | Genovefa Kolovou, MD, PhD, Aleksandros Tsoutsinos, MD, Irene Mastorakou, MD, MSc, PhD, Sophie Mavrogeni, MD, PhD, George Hatzigeorgiou, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | JACC: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666084919302438 |
Similar Items
-
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
by: Laura D’Erasmo, et al.
Published: (2021-09-01) -
Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
by: Dirk J. Blom, et al.
Published: (2018-06-01) -
Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial
by: Antonio Carlos Amedeo Vattimo, MD, MSc, et al.
Published: (2020-01-01) -
Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus
by: Bai, B., et al.
Published: (2022) -
The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia
by: Suleiman Ehab S, et al.
Published: (2004-10-01)